NCT05548296 2026-05-14A Phase 2 Study of ACR-368 in Endometrial AdenocarcinomaAcrivon TherapeuticsPhase 2 Recruiting401 enrolled
NCT06597565 2025-10-20A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCCH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Recruiting43 enrolled